Hit Generation

Hit Generation is a methodological contribution in de novo drug design that identifies novel chemical compounds with desired biological activity through computational or experimental screening, distinguished from other approaches by its focus on discovering initial active candidates (hits) prior to optimization.

41

Publications

2K

Citations

340

Authors

62

Institutions

Publications per year

2017–2026

14

Authors

340

  1. GT
    Gary Tresadern

    Janssen (Belgium), Belgium

    2 publications · 97 citations

    2

    h-index

  2. PN
    Pierre Nimsgern

    Novartis (Switzerland), Switzerland

    2 publications · 85 citations

    2

    h-index

  3. FR
    Frederik Rombouts

    Janssen (Belgium), Belgium

    2 publications · 97 citations

    2

    h-index

  4. AV
    Ann Vos

    Janssen (Belgium), Belgium

    2 publications · 97 citations

    2

    h-index

  5. AA
    Andrés A. Trabanco

    Janssen (Belgium), Belgium

    2 publications · 97 citations

    2

    h-index

1–5 of 340

Venues

  1. Journal of Medicinal Chemistry

    9 publications · 488 citations

    9

    h-index

  2. ChemMedChem

    3 publications · 141 citations

    3

    h-index

  3. Journal of Chemical Information and Modeling

    JCIM · 1 publications · 52 citations

    2

    h-index

  4. ACS Medicinal Chemistry Letters

    2 publications · 67 citations

    2

    h-index

  5. PubMed

    Repository · 2 publications · 89 citations

    2

    h-index

1–5